Targeting PI3Kδ for lymphoma and immune diseases treatment: a review.
APA
Jia W (2026). Targeting PI3Kδ for lymphoma and immune diseases treatment: a review.. Molecular diversity. https://doi.org/10.1007/s11030-026-11536-z
MLA
Jia W. "Targeting PI3Kδ for lymphoma and immune diseases treatment: a review.." Molecular diversity, 2026.
PMID
41934567
같은 제1저자의 인용 많은 논문 (5)
- Intelligent catalase-coated MnO nanoparticles with programmed oxygen supply and glutathione depletion for enhanced photodynamic therapy.
- Multitarget natural compounds taming NETosis: A translational strategy for cancer and inflammatory diseases.
- Effects of Oxycodone versus Sufentanil-Based Intravenous Patient-Controlled Multimodal Analgesia on Early Gastrointestinal Recovery and Pain After Laparoscopic Colorectal Cancer Surgery: A Randomized Double-Blind Trial.
- From diagnosis and treatment to prognosis: Clinical prospects of artificial intelligence in multimodal research of hepatocellular carcinoma.
- Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway.